Biogazelle is gold sponsor of the 4th Global Precision Medicine & Biomarkers Leaders Summit in Munich
We look forward to seeing you at the 4th Global Precision Medicine & Biomarkers Leaders Summit. While at the Congress, drop by at Biogazelle's Booth (#12) to learn more about Biogazelle's products and services.
Biogazelle offers unique mRNA sequencing on plasma
This month, Biogazelle launches a novel and unique application: mRNA sequencing on human plasma. mRNA sequencing on plasma – or other body fluids – has not yet been offered by other sequencing service providers. This powerful new application allows researchers to maximize the biomarker potential from valuable plasma samples, to find relevant disease or treatment response biomarkers.
Biogazelle presents ‘RNA capture sequencing’ at Revolutionizing next-generation sequencing in Antwerp
Biogazelle’s CSO prof. Jo Vandesompele presented Biogazelle’s strategy and expertise to deploy RNA in liquid biopsies to further diagnostic applications and drug development at “Revolutionizing next-generation sequencing” (Antwerp, Belgium).
Biogazelle offers mRNA sequencing on plasma – interview with CSO prof. Jo Vandesompele
Biogazelle was one of the first to offer microRNA expression profiling of challenging samples such as RNA from body fluids or archived tissues. Further building on its longstanding track record and internationally recognized expertise in RNA gene expression analysis, Biogazelle subsequently extended its portfolio with mRNA and total RNA sequencing on FFPE tissue. Today, Biogazelle closes the gap with a new and unique offer, namely the use of massively parallel sequencing to quantify and characterize mRNA in plasma. Biogazelle’s CSO prof. Jo Vandesompele is very excited about this new application Biogazelle offers to its customers today. In this interview, he elaborates on the unique nature and the value of this product.